In February 2021, the FDA issued a guidance aimed at preventing unacceptable levels of nitrosamine impurities in pharmaceutical products. This guidance required a risk assessment to be completed by March 31, 2021. This is Read more
Improved Pharma is pleased to announce the open-source publication of research into finding new salts of bedaquiline, an important drug for the treatment of tuberculosis. The drug is currently marketed in the US as Read more
WEST LAFAYETTE, IND. (PRWEB) OCTOBER 26, 2020 Interact with us via poster number 924440 and the Advances and Innovation in Formulation Development Rapid Fire session. On Wednesday October 28th, Dr. Pamela Smith, COO of Improved Read more
Improved Pharma COO Pamela Smith is co-author of a chapter in the latest edition of Specification of Drug Substances and Products: Development and Validation of Analytical Methods. The chapter, Solid-State Characterization – Method Development and Read more
Traditionally, excipients utilized for the development of pharmaceutically-marketed drug products have been considered largely inert. Excipients are added to formulations for a variety of reasons that may include assisting processability of the drug product formulation, Read more
WEST LAFAYETTE, IND. (PRWEB) SEPTEMBER 15, 2020 Improved Pharma has expanded their offerings by acquiring S. I. Photonics’ top-of-the-line spectrophotometer, model 440. This model has a high sensitivity, low noise CCD detector that enables the collection Read more
WEST LAFAYETTE, IND. (PRWEB) JULY 20, 2020 Improved Pharma is pleased to announce new collaborations with Westport Pharmaceutical Consulting, LLC (dba WPC, LLC) and Ravine Pharmaceuticals LLC enabling expansion of expertise and service offerings to Read more
Polymorph screens and salt screens are important components for drug development. The goal of polymorph screening is to try to find all possible crystal forms by small-scale crystallization and to select a stable form that Read more
Accelerated development is a complex and difficult task. S-fIND (Synchrotron-based fast to IND) is a strategy to speed development of the most difficult cases using powerful X-ray methods only available at a Synchrotron X-ray source. S-fIND Read more
WEST LAFAYETTE, IND. (PRWEB) JUNE 02, 2020 In response to growing demands for services, Improved Pharma, LLC is pleased to announce a collaboration with Dr. Dale K. Purcell of Chemical Microscopy, LLC to provide services related to microscopy Read more
